NCT07126626View on ClinicalTrials.gov

Validation of the SPOT-MAS Lung Test Using Circulating Tumor DNA for the Detection of Lung Cancer

Not yet recruitingOBSERVATIONAL
Enrollment

1,184

Participants

Timeline

Start Date

August 18, 2025

Primary Completion Date

July 31, 2027

Study Completion Date

July 31, 2027

Conditions
Lung DiseasesLung Cancer Screening
Trial Locations (1)

Unknown

Medical Genetics Institute, Ho Chi Minh City

Sponsors

Lead Sponsor

Gene Solutions
All Listed Sponsors
lead

Gene Solutions

INDUSTRY

NCT07126626 - Validation of the SPOT-MAS Lung Test Using Circulating Tumor DNA for the Detection of Lung Cancer | Biotech Hunter | Biotech Hunter